openPR Logo
Press release

Acne Vulgaris Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Treatment Outlook, and Key Companies | Novan, Bausch Health Americas, AOBiome, Ascle

05-16-2023 07:15 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Acne Vulgaris Pipeline Assessment (2023 Updates) | In-depth

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 22+ key pharma and biotech companies are working on 22+ pipeline drugs in the Acne Vulgaris therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Acne Vulgaris Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acne Vulgaris Therapeutics Market.

The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).

The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Acne Vulgaris Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing therapies in the Acne Vulgaris Market.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acne Vulgaris treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Acne Vulgaris market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Learn More about the Clinical and Commercial Development Activities in the Acne Vulgaris Therapeutics Domain:
https://www.delveinsight.com/report-store/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Route of Administration
Acne Vulgaris pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Acne Vulgaris Therapeutics Analysis
There are approx. 22+ key companies developing therapies for Acne Vulgaris. Currently, Bausch Health Americas, Inc. is leading the therapeutics market with its Acne vulgaris drug candidates in the most advanced stage of clinical development.

The Leading Companies in the Acne Vulgaris Therapeutics Market Include:
• Novan, Inc.
• Bausch Health Americas, Inc.
• AOBiome LLC
• Ascletis Pharmaceuticals
• AnaptysBio, Inc.
• Botanix Pharmaceuticals
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
• Xenon Pharmaceuticals Inc.
• Origimm Biotechnology
• Boston Pharmaceuticals
• Kintor Pharma
• Dermavant Sciences
• Eligo Bioscience
• Cassiopea, Inc.
• BioPharmX
• Madam Therapeutics
• SiSaf
And Many Others

Acne Vulgaris Emerging and Marketed Therapies Covered in the Report Include:
• IDP126: Bausch Health Americas, Inc.
• DMT310: Dermata Therapeutics
And Many More

Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Acne Vulgaris Current Treatment Patterns
4. Acne Vulgaris - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acne Vulgaris Late-Stage Products (Phase-III)
7. Acne Vulgaris Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acne Vulgaris Discontinued Products
13. Acne Vulgaris Product Profiles
14. Acne Vulgaris Key Companies
15. Acne Vulgaris Key Products
16. Dormant and Discontinued Products
17. Acne Vulgaris Unmet Needs
18. Acne Vulgaris Future Perspectives
19. Acne Vulgaris Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/acne-vulgaris-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Other Trending Healthcare Reports by DelveInsight
Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market

Nephrosclerosis Market
https://www.delveinsight.com/report-store/nephrosclerosis-market

Nocturnal Enuresis Market
https://www.delveinsight.com/report-store/nocturnal-enuresis-market

Undifferentiated Pleomorphic Sarcoma Market
https://www.delveinsight.com/report-store/undifferentiated-pleomorphic-sarcoma-market

Mucinous cystic neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Adenosine Deaminase-Severe Combined Immunodeficiency Market
https://www.delveinsight.com/report-store/adenosine-deaminase-severe-combined-immunodeficiency-market

Metastatic Cutaneous Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/metastatic-cutaneous-squamous-cell-carcinoma-market

Insulin Glargine Biosimilar
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight

HDAC Inhibitors Market
https://www.delveinsight.com/report-store/hdac-inhibitors-market

Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market

mRNA Vaccine and Therapeutics Market
https://www.delveinsight.com/report-store/mrna-vaccine-and-therapeutics-market

Asthma Diagnostic Devices Market
https://www.delveinsight.com/report-store/asthma-diagnostic-devices-market

Holter Monitor Market
https://www.delveinsight.com/report-store/holter-monitor-market

Total Knee Arthroplasty Market
https://www.delveinsight.com/report-store/total-knee-arthroplasty-market

Sacral Nerve Stimulator Devices Market
https://www.delveinsight.com/report-store/sacral-nerve-stimulator-devices-market

Cardiac Monitoring System Market
https://www.delveinsight.com/report-store/cardiac-monitoring-system-market

Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market

Spirometers Market
https://www.delveinsight.com/report-store/spirometers-market

Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market

Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market

Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market

Negative Pressure Wound Therapy Systems Market
https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market

India Healthcare Outlook Report
https://www.delveinsight.com/report-store/india-healthcare-outlook-report

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acne Vulgaris Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Treatment Outlook, and Key Companies | Novan, Bausch Health Americas, AOBiome, Ascle here

News-ID: 3056031 • Views:

More Releases from DelveInsight Business Research LLP

Oncolytic Virus Cancer Therapy Market | Companies involved: Targovax, Replimune, Genelux Corporation, Candel Therapeutics, DNAtrix, SillaJen, Treovir, Lokon Pharma AB, Istari Oncology, CG Oncology, Amgen, Daiichio Sankyo
Oncolytic Virus Cancer Therapy Market | Companies involved: Targovax, Replimune, …
DelveInsight's "Oncolytic Virus Cancer Therapy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oncolytic Virus Cancer Therapy, historical and forecasted epidemiology as well as the Oncolytic Virus Cancer Therapy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Oncolytic Virus Cancer Therapy market report provides current treatment practices, emerging drugs, Oncolytic Virus Cancer Therapy market share of the
Lymphocytopenia Market to Witness Growth | AbbVie Inc, BristolMyersSquibb, CSL Ltd., Gilead Sciences Inc., GSK Plc, Grifols SA, Johnson & Johnson, Merck & Co., Novartis AG, Sanofi S.A., and others
Lymphocytopenia Market to Witness Growth | AbbVie Inc, BristolMyersSquibb, CSL L …
DelveInsight's "Lymphocytopenia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Lymphocytopenia, historical and forecasted epidemiology as well as the Lymphocytopenia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Lymphocytopenia market report provides current treatment practices, emerging drugs, Lymphocytopenia market share of the individual therapies, and current and forecasted Lymphocytopenia market size from 2019 to 2032 segmented by
Complex Regional Pain Syndrome Market to Witness Growth by 2032 |Ovid therapeutics, AstraZeneca, Abbott, GSK, Viatris and Johnson & Johnson Services, and others
Complex Regional Pain Syndrome Market to Witness Growth by 2032 |Ovid therapeuti …
DelveInsight's "Complex Regional Pain Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Complex Regional Pain Syndrome, historical and forecasted epidemiology as well as the Complex Regional Pain Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Complex Regional Pain Syndrome market report provides current treatment practices, emerging drugs, Complex Regional Pain Syndrome market share of the
Meningitis Market to Witness Growth by 2032 | Bausch Health Companies Inc., Mylan N.V., Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Aurobindo Pharma, Beximco Pharmaceuticals Ltd, Hikma Pharmaceuticals PLC, Astral SteriTech Pvt., a
Meningitis Market to Witness Growth by 2032 | Bausch Health Companies Inc., Myla …
DelveInsight's "Meningitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningitis, historical and forecasted epidemiology as well as the Meningitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Meningitis market report provides current treatment practices, emerging drugs, Meningitis market share of the individual therapies, and current and forecasted Meningitis market size from 2019 to 2032 segmented by

All 5 Releases


More Releases for Acne

Rising Cases of Acne Boosting Professional Acne Treatment Market Growth
Factor such as the rising cases of acne, surging adoption of acne treatments, growing healthcare spending, increasing disposable income, sedentary lifestyle, strong product pipeline, and mounting number of research programs are expected to propel the professional acne treatment market at a CAGR of 7.6% during 2020–2030. According to P&S Intelligence, the market size is expected to reach $13,124.5 million by 2030 from $6,298.9 million in 2020. Moreover, the market is
Acne Drugs: Global Markets
The global market for acne drugs was valued at REDACTED in 2019. The market is expected to growat a compound annualgrowth rate (CAGR) of REDACTED to reach REDACTED by 2025. Growth of the global market is attributed the increasing numberof cases of acne and skin diseases, unhealthy eating habits and the rising adoption of skin care productsworldwide. To Get Sample Copy of Report Visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2798596 Increasing prevalence of the acne and
Acne Drugs Market
According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global acne drugs market to continue its moderate growth during the next five years. Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of
Acne Vulgaris Treatment Market
Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. It is commonly observed in adolescent population, however, can also affect adults. Depending on its severity, acne may be segmented into mild, moderate or severe. It is caused due to excess oil produced in sebaceous glands under skin, which becomes plugged and inflated. Female patient with polycystic ovarian syndrome
Global Market Study on Acne Treatment Inflammatory Acne Segment Anticipated.
The global acne treatment market is stagnant in terms of incremental innovation as most players are investing in product reformulation instead of new product development. The analysts of Persistence Market Research have come up with a new publication titled “Acne Treatment Market: Global Industry Analysis and Forecast, 2017 – 2025,” and have observed that the North America region is expected to witness significant growth in market revenue due to rising affinity
Acne solution
Understanding acne and the different types of acne people suffer from can help in determining what methods of acne control should be attempted, without risk of worsening the condition, or possibly causing permanent damage to the skin. The medical community has had no luck in pinpointing the exact cause of acne and a single effective method for acne control, but the source of acne has been discovered to be the